Cardima gets Canadian nod for AF (atrial fibrillation) mictrocatheters:
This article was originally published in Clinica
Cardima has gained the green light in Canada to market its REVELATION family of ablation microcatheters as a treatment for atrial fibrillation (AF). The Revelation Tx, Revelation T-Flex and Revelation Helix microcatheters can be used in a minimally invasive version of a surgical treatment for AF, called MAZE. They allow surgeons to create straight, curved and circumferential linear endocardial lesions to treat the condition. Cardima, of Fremont, California has already submitted a marketing application to the US FDA for the Revelation Tx device.